Peringatan Keamanan

Acute oral toxicity (LD50): 9100 mg/kg in the mouse MSDS

Toxicity from overdose is rare but may result from intentional ingestion of potassium. Iatrogenic overdoses may occur L2653.

Local irritation after ingestion causes GI upset. Severe hyperkalemia after large IV or oral overdoses causes muscular dysfunction including weakness, paralysis, cardiac dysrhythmias, and rarely death L2653.

Mild to moderate toxicity

Nausea, vomiting, diarrhea, paresthesias, and muscle cramps are common. Rarely, gastrointestinal bleed may occur.

Severe toxicity

In severe toxicity, muscular weakness progressing to paralysis may occur. Cardiac arrhythmia often occur at concentrations greater than 8 mEq/L and death from cardiac arrest at concentrations of 9 to 12 mEq/L or higher. Characteristic ECG findings occur in the following order: peaked T waves, QRS complex blends into the T wave, PR interval prolongation, P wave is lost and ST segments depress, merging S and T waves, and finally, sine waves. The presence of the sine wave is a near terminal event, signaling that hemodynamic collapse and cardiac arrest are near. As serum hyperkalemia is corrected towards normal concentrations, the ECG changes resolve in reverse order L2653.

Potassium gluconate

DB13620

small molecule approved

Deskripsi

Potassium gluconate is a salt of DB01345 and is classified as a food additive by the FDA L2654. It is also used as a potassium supplement L2657.

Potassium is an essential nutrient. It is the most abundant cation in the intracellular fluid, where it plays a key role in maintaining cell function A32222.

In dietary supplements, potassium is often present as potassium chloride, but many other forms—including potassium citrate, phosphate, aspartate, bicarbonate, and gluconate—are also used L2652. Potassium gluconate is believed to be more palatable and non-acidifying than potassium chloride (KCl) L2658.

Struktur Molekul 2D

Berat 234.245
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi Distribution is largely intracellular, but it is the intravascular concentration that is primarily responsible for toxicity [L2653].
Klirens (Clearance) Potassium is freely filtered by the glomerulus in the kidney. The majority of filtered potassium is reabsorbed in the proximal tubule and loop of Henle. Less than 10% of the filtered load reaches the distal nephron. In the proximal tubule of the nephron, potassium absorption is mainly passive and proportional to Na+ and water. K+ reabsorption in the thick ascending limb of Henle occurs through both transcellular and paracellular pathways. The transcellular component is regulated by potassium transport on the apical membrane Na+-K+-2Cl? cotransporter. The secretion of potassium begins in the early distal convoluted tubule of the nephron and progressively increases along the distal nephron into the cortical collecting duct. Most urinary K+ can be accounted for by electrogenic K+ secretion mediated by principal cells in the initial collecting duct and the cortical collecting duct. An electroneutral K+ and Cl? cotransport mechanism is also present on the apical surface of the distal nephron. Under conditions of potassium deficiency, reabsorption of the cation occurs in the collecting duct. This process is regulated by the upregulation in the apically located H+-K+-ATPase on ?-intercalated cells [L2660].

Absorpsi

Potassium is rapidly and well absorbed. A 2016 dose-response trial found that humans absorb about 94% of potassium gluconate in supplements, and this absorption rate is similar to that of potassium from potatoes A32902.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

90% of potassium is eliminated via the kidneys. A small amount is eliminated in feces and sweat L2653.

Interaksi Obat

289 Data
Ramipril The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Ramipril.
Fosinopril The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Fosinopril.
Trandolapril The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Trandolapril.
Benazepril The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Benazepril.
Enalapril The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Enalapril.
Moexipril The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Moexipril.
Lisinopril The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Lisinopril.
Perindopril The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Perindopril.
Quinapril The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Quinapril.
Omapatrilat The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Omapatrilat.
Rescinnamine The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Rescinnamine.
Captopril The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Captopril.
Cilazapril The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Cilazapril.
Spirapril The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Spirapril.
Temocapril The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Temocapril.
Enalaprilat The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Enalaprilat.
Imidapril The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Imidapril.
Zofenopril The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Zofenopril.
Delapril The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Delapril.
Benazeprilat The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Benazeprilat.
Fosinoprilat The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Fosinoprilat.
Ramiprilat The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Ramiprilat.
Trandolaprilat The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Trandolaprilat.
Moexiprilat The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Moexiprilat.
Perindoprilat The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Perindoprilat.
Quinaprilat The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Quinaprilat.
Cilazaprilat The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Cilazaprilat.
Triamterene The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Triamterene.
Spironolactone The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Spironolactone.
Amiloride The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Amiloride.
Eplerenone The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Eplerenone.
Canrenoic acid The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Canrenoic acid.
Canrenone The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Canrenone.
Valsartan Potassium gluconate may increase the hyperkalemic activities of Valsartan.
Olmesartan Potassium gluconate may increase the hyperkalemic activities of Olmesartan.
Losartan Potassium gluconate may increase the hyperkalemic activities of Losartan.
Candesartan cilexetil Potassium gluconate may increase the hyperkalemic activities of Candesartan cilexetil.
Eprosartan Potassium gluconate may increase the hyperkalemic activities of Eprosartan.
Telmisartan Potassium gluconate may increase the hyperkalemic activities of Telmisartan.
Irbesartan Potassium gluconate may increase the hyperkalemic activities of Irbesartan.
Forasartan Potassium gluconate may increase the hyperkalemic activities of Forasartan.
Saprisartan Potassium gluconate may increase the hyperkalemic activities of Saprisartan.
Tasosartan Potassium gluconate may increase the hyperkalemic activities of Tasosartan.
Saralasin Potassium gluconate may increase the hyperkalemic activities of Saralasin.
Azilsartan medoxomil Potassium gluconate may increase the hyperkalemic activities of Azilsartan medoxomil.
Fimasartan Potassium gluconate may increase the hyperkalemic activities of Fimasartan.
Candesartan Potassium gluconate may increase the hyperkalemic activities of Candesartan.
Cyclosporine Potassium gluconate may increase the hyperkalemic activities of Cyclosporine.
Icosapent Potassium gluconate may increase the hyperkalemic activities of Icosapent.
Esmolol Potassium gluconate may increase the hyperkalemic activities of Esmolol.
Betaxolol Potassium gluconate may increase the hyperkalemic activities of Betaxolol.
Fluconazole Potassium gluconate may increase the hyperkalemic activities of Fluconazole.
Succinylcholine Potassium gluconate may increase the hyperkalemic activities of Succinylcholine.
Mesalazine Potassium gluconate may increase the hyperkalemic activities of Mesalazine.
Metoprolol Potassium gluconate may increase the hyperkalemic activities of Metoprolol.
Isradipine Potassium gluconate may increase the hyperkalemic activities of Isradipine.
Indomethacin Potassium gluconate may increase the hyperkalemic activities of Indomethacin.
Atenolol Potassium gluconate may increase the hyperkalemic activities of Atenolol.
Diltiazem Potassium gluconate may increase the hyperkalemic activities of Diltiazem.
Trimethadione Potassium gluconate may increase the hyperkalemic activities of Trimethadione.
Timolol Potassium gluconate may increase the hyperkalemic activities of Timolol.
Amlodipine Potassium gluconate may increase the hyperkalemic activities of Amlodipine.
Digoxin Potassium gluconate may increase the hyperkalemic activities of Digoxin.
Nimodipine Potassium gluconate may increase the hyperkalemic activities of Nimodipine.
Nisoldipine Potassium gluconate may increase the hyperkalemic activities of Nisoldipine.
Ardeparin Potassium gluconate may increase the hyperkalemic activities of Ardeparin.
Trimethoprim Potassium gluconate may increase the hyperkalemic activities of Trimethoprim.
Nabumetone Potassium gluconate may increase the hyperkalemic activities of Nabumetone.
Ketorolac Potassium gluconate may increase the hyperkalemic activities of Ketorolac.
Tenoxicam Potassium gluconate may increase the hyperkalemic activities of Tenoxicam.
Celecoxib Potassium gluconate may increase the hyperkalemic activities of Celecoxib.
Sotalol Potassium gluconate may increase the hyperkalemic activities of Sotalol.
Tolmetin Potassium gluconate may increase the hyperkalemic activities of Tolmetin.
Lercanidipine Potassium gluconate may increase the hyperkalemic activities of Lercanidipine.
Rofecoxib Potassium gluconate may increase the hyperkalemic activities of Rofecoxib.
Piroxicam Potassium gluconate may increase the hyperkalemic activities of Piroxicam.
Lamotrigine Potassium gluconate may increase the hyperkalemic activities of Lamotrigine.
Cinnarizine Potassium gluconate may increase the hyperkalemic activities of Cinnarizine.
Propranolol Potassium gluconate may increase the hyperkalemic activities of Propranolol.
Fenoprofen Potassium gluconate may increase the hyperkalemic activities of Fenoprofen.
Valdecoxib Potassium gluconate may increase the hyperkalemic activities of Valdecoxib.
Diclofenac Potassium gluconate may increase the hyperkalemic activities of Diclofenac.
Ethosuximide Potassium gluconate may increase the hyperkalemic activities of Ethosuximide.
Labetalol Potassium gluconate may increase the hyperkalemic activities of Labetalol.
Sulindac Potassium gluconate may increase the hyperkalemic activities of Sulindac.
Bisoprolol Potassium gluconate may increase the hyperkalemic activities of Bisoprolol.
Nicardipine Potassium gluconate may increase the hyperkalemic activities of Nicardipine.
Magnesium sulfate Potassium gluconate may increase the hyperkalemic activities of Magnesium sulfate.
Nitrofurantoin Potassium gluconate may increase the hyperkalemic activities of Nitrofurantoin.
Flurbiprofen Potassium gluconate may increase the hyperkalemic activities of Flurbiprofen.
Pentamidine Potassium gluconate may increase the hyperkalemic activities of Pentamidine.
Mannitol Potassium gluconate may increase the hyperkalemic activities of Mannitol.
Etodolac Potassium gluconate may increase the hyperkalemic activities of Etodolac.
Potassium chloride Potassium gluconate may increase the hyperkalemic activities of Potassium chloride.
Mefenamic acid Potassium gluconate may increase the hyperkalemic activities of Mefenamic acid.
Naproxen Potassium gluconate may increase the hyperkalemic activities of Naproxen.
Sulfasalazine Potassium gluconate may increase the hyperkalemic activities of Sulfasalazine.
Phenylbutazone Potassium gluconate may increase the hyperkalemic activities of Phenylbutazone.
Meloxicam Potassium gluconate may increase the hyperkalemic activities of Meloxicam.
Carprofen Potassium gluconate may increase the hyperkalemic activities of Carprofen.

Referensi & Sumber

Artikel (PubMed)
  • PMID: 27455317
    Stone MS, Martyn L, Weaver CM: Potassium Intake, Bioavailability, Hypertension, and Glucose Control. Nutrients. 2016 Jul 22;8(7). pii: nu8070444. doi: 10.3390/nu8070444.
  • PMID: 27413123
    Macdonald-Clarke CJ, Martin BR, McCabe LD, McCabe GP, Lachcik PJ, Wastney M, Weaver CM: Bioavailability of potassium from potatoes and potassium gluconate: a randomized dose response trial. Am J Clin Nutr. 2016 Aug;104(2):346-53. doi: 10.3945/ajcn.115.127225. Epub 2016 Jul 13.

Contoh Produk & Brand

Produk: 21 • International brands: 1
Produk
  • Cal-mag Plus K, Mn and Zn Caplets
    Tablet • - • Oral • Canada • OTC • Approved
  • Flexadyn Tab
    Tablet • - • Oral • Canada • OTC • Approved
  • Formula BP
    Tablet • - • Oral • Canada • Approved
  • Iode-potassium
    Tablet • - • Oral • Canada • OTC • Approved
  • Kaon
    Elixir • 4.68 g / 15 mL • Oral • Canada • OTC • Approved
  • Men's Multi Master Formula
    Tablet • - • Oral • Canada • OTC • Approved
  • Multivitamins and Minerals for Young Men
    Tablet • - • Oral • Canada • OTC • Approved
  • Multivitamins and Minerals for Young Women
    Tablet • - • Oral • Canada • OTC • Approved
Menampilkan 8 dari 21 produk.
International Brands
  • Gluconsan-K

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul